Table 2.
Consultants’ versus residents’ outcomes.
| Variables | Group 1 | Group 2 | P |
|---|---|---|---|
| AGE (years) Median, IQR |
72 (66–78) | 68 (63–73) | 0.001 |
| PV (mL) Median, IQR |
51 (37–68) | 56 (40–84) | 0.106 |
| BMI (kg/m2) Median, IQR |
26.2 (22.8–28.1) | 25.1 (21.8–28.9) | 0.578 |
| PSA (ng/mL) Median, IQR |
6.7 (5.4–9.4) | 7.0 (4.4–10.4) | 0.571 |
| VAS Median, IQR |
2 (0–2) | 2 (0–2.5) | 0.774 |
| PI-RADS of L1 (1–5) | 70 | 70 | 0.013 |
| (n) (%) | |||
| 1 | 0/70 (0.0) | 0/70 (0.0) | |
| 2 | 8/70 (11.4) | 9/70 (12.9) | |
| 3 | 17/70 (24.3) | 33/70 (47.1) | |
| 4 | 31/70 (44.3) | 22/70 (31.4) | |
| 5 | 14/70 (20.0) | 6/70 (8.6) | |
| PI-RADS of L2 (1–5) | 10 | 9 | 0.758 |
| (n) (%) | |||
| 1 | 0 (0.0) | 0 (0.0) | |
| 2 | 4 (40.0) | 1 (11.1) | |
| 3 | 3 (30.0) | 7 (77.8) | |
| 4 | 3 (30.0) | 1 (11.1) | |
| 5 | 0 (0.0) | 0 (0.0) | |
| Size (mm) | 8 (6/12) | 9 (7/13) | 0.354 |
| Location (anterior/peripheral) | 10/60 | 12/58 | 0.642 |
| Length (mm) Median, IQR |
9 (8–13) | 10 (9–12) | 0.572 |
| Max cancer length | 5 (3/6) | 4 (3/7) | 0.898 |
| Cores for L1 (n) Median, IQR |
3 (3–3) | 3 (3–5) | 0.923 |
| Cores for L2 (n) Median, IQR |
3 (2–3) | 3 (3–3) | 0.038 |
| Positive cores L1 (n) Median, IQR |
0.5 (0.0- 3.0) | 0 (0–2) | 0.104 |
| Positive cores L2 (n) Median, IQR |
1 (0–3) | 0 (0–0) | 0.135 |
| Procedure time (min) Median, IQR |
10 (8–12) | 9 (8–12) | 0.143 |
| PCa (n) (%) | 37 (52.9) | 32 (45.7) | 0.499 |
| ISUP Grade (1–5) | 37 (100) | 32 (100) | 0.196 |
| (n) (%) | |||
| 1 | 3 (8.1) | 6 (18.8) | |
| 2 | 4 (10.8) | 3 (9.4) | |
| 3 | 5 (13.5) | 5 (15.6) | |
| 4 | 10 (27) | 9 (28.1) | |
| 5 | 15 (40.5) | 9 (28.1) | |
| Complications | |||
| (n) (%) | |||
| Haematospermia | 18/70 (26%) | 20/70 (28%) | 0.345 |
| Haematuria | 5/70 (7%) | 7/70 (10%) | 0.432 |
| Rectal Bleeding | 1/70 | 0/70 | 0.833 |
| Fever > 38.5° | 0/70 | 0/70 | 1.000 |
| AUR * | 1/70 | 1/70 | 1.000 |
* Acute Urinary Retention.